Lumbrokinase pill for moderate-to-severe stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a medicine called lumbrokinase, given as a pill, to see if it helps people recover from a moderate-to-severe ischemic stroke. It is compared to a placebo (a pill with no active medicine). The goal is to find a treatment that can be given soon after a stroke, without needing clot-busting shots or procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had an ischemic stroke (a clot blocking blood flow in the brain) that was confirmed by a CT or MRI scan.
- You can be randomized within 24 hours of the start of stroke symptoms.
- Before this stroke, you were able to live independently (no major disabilities).
- You have not already received clot-busting treatment or a procedure to remove the clot for this stroke.
- You do not have heart conditions like atrial fibrillation, or other causes of stroke like arterial dissection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of a new clot-dissolving medicine for people who had a stroke 4.5 to 24 hours ago. It may help if you cannot have standard treatments like a clot-removal procedure or other clot-busting drugs.
This study tests an investigational injectable drug called LT3001 that may help dissolve blood clots in the brain after a stroke. It is given within 24 hours of stroke onset, and the goal is to reduce disability and improve recovery.
This study tests whether a clot-busting drug called pro-urokinase can help people with a stroke in the back of the brain when given later than usual (4.5 to 9 hours after symptoms start). The goal is to see if it improves recovery and reduces disability.
This trial tests whether the clot-busting drug urokinase can help people who have had an ischemic stroke (a stroke caused by a blood clot). The goal is to dissolve the clot and improve recovery, as long as treatment starts within 6 hours of the first symptoms.
This study tests whether a medication called a GLP-1 receptor agonist (a type of drug used for diabetes) can improve recovery after a major stroke that was treated with a procedure to remove the blood clot. The goal is to see if this drug helps reduce further brain damage and improve outcomes.
This trial tests a medicine called tenecteplase (a clot-buster) for people who have a moderate or severe stroke caused by a clot and can be treated 4.5 to 6 hours after symptoms start. It aims to see if this medicine can help improve recovery.
Hear when a new Ischemic Stroke, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.